- Home
- IVR vs VOR Comparison
IVR vs VOR Comparison
Compare IVR & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IVR | VOR |
|---|---|---|
| Founded | 2008 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 625.3M | 562.6M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | IVR | VOR |
|---|---|---|
| Price | $7.66 | $12.08 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 11 |
| Target Price | $8.25 | ★ $61.30 |
| AVG Volume (30 Days) | ★ 2.1M | 603.6K |
| Earning Date | 05-06-2026 | 03-20-2026 |
| Dividend Yield | ★ 17.82% | N/A |
| EPS Growth | N/A | ★ 2.86 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $150.63 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $6.63 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.86 | $0.13 |
| 52 Week High | $9.50 | $49.95 |
Technical Indicators
Market Signals| Indicator | IVR | VOR |
|---|---|---|
| Relative Strength Index (RSI) | 28.01 | 38.45 |
| Support Level | $7.52 | $11.76 |
| Resistance Level | $7.90 | $16.88 |
| Average True Range (ATR) | 0.22 | 1.02 |
| MACD | -0.04 | -0.30 |
| Stochastic Oscillator | 2.65 | 0.47 |
Price Performance
Historical ComparisonAbout IVR INVESCO MORTGAGE CAPITAL INC
Invesco Mortgage Capital Inc is a REIT that invests, finances, and manages residential and commercial mortgage-backed securities and mortgage loans. The company's portfolio consists of residential mortgage-backed securities (RMBS) that are guaranteed by a U.S. government agency such as the Government National Mortgage Association, or a federally chartered corporation such as the Federal National Mortgage Association or the Federal Home Loan Mortgage Corporation; Commercial mortgage-backed securities (CMBS) that are not guaranteed by a U.S. government agency or a federally chartered corporation; RMBS that are not guaranteed by a U.S. government agency or a federally chartered corporation; and other real estate-related financing arrangements.
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.